Shorting stocks has been a coin-flip in 2025, with almost 50% of short positions unprofitable this year, S3 Partners said.

The U.S. Food and Drug Administration has cracked down on compounded drugs, which were readily available while the patented ...

Both Nvidia and Tesla have benefited from individual catalysts throughout the run. For Nvidia, easing trade restrictions have been a boost for the AI chip leader headed into its next earnings release ...

CompanyOverview|NYSE:ACHR] A recent report from short-seller Culper Research on May 20, 2025, cast a shadow over Archer ...

A bold $60M leveraged bet on Ethereum futures trading fuels gains and short liquidations, highlighting rising bullish ...

As strategists have digested the large move higher in stocks that recently brought the S&P 500 back within 3% of its record close, some believe short-covering helped contribute to the rally as ...

Nevertheless, some experts believe that the rally was fueled more by investors closing out bearish bets (short-covering) rather than by strong business fundamentals. Viktor Hjort from BNP Paribas ...

Compounding pharmacies are supposed to stop producing the compounded versions of the popular weight loss medications now that ...